HEADER RNA BINDING PROTEIN 20-JAN-04 1V95 TITLE SOLUTION STRUCTURE OF ANTICODON BINDING DOMAIN FROM NUCLEAR RECEPTOR TITLE 2 COACTIVATOR 5 (HUMAN KIAA1637 PROTEIN) COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 5; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ANTICODON BINDING DOMAIN; COMPND 5 SYNONYM: NCOA-5, COACTIVATOR INDEPENDENT OF AF-2, CIA; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KAZUSA CDNA FJ00747S1; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: P030506-92; SOURCE 8 OTHER_DETAILS: CELL-FREE PROTEIN SYNTHESIS KEYWDS NUCLEAR RECEPTOR COACTIVATOR 5, COACTIVATOR INDEPENDENT OF AF-2 KEYWDS 2 FUNCTION (CIA), STRUCTURAL GENOMICS, RIKEN STRUCTURAL KEYWDS 3 GENOMICS/PROTEOMICS INITIATIVE, RSGI, RNA BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR C.ZHAO,T.KIGAWA,N.TOCHIO,S.KOSHIBA,M.INOUE,S.YOKOYAMA,RIKEN AUTHOR 2 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 4 27-DEC-23 1V95 1 REMARK REVDAT 3 02-MAR-22 1V95 1 REMARK SEQADV REVDAT 2 24-FEB-09 1V95 1 VERSN REVDAT 1 20-JUL-04 1V95 0 JRNL AUTH C.ZHAO,T.KIGAWA,N.TOCHIO,S.KOSHIBA,M.INOUE,S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF ANTICODON BINDING DOMAIN FROM NUCLEAR JRNL TITL 2 RECEPTOR COACTIVATOR 5 (HUMAN KIAA1637 PROTEIN) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 2.6, CYANA 1.0.7 REMARK 3 AUTHORS : BRUKER (XWINNMR), GUENTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1V95 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-JAN-04. REMARK 100 THE DEPOSITION ID IS D_1000006362. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298.0 REMARK 210 PH : 7.5 REMARK 210 IONIC STRENGTH : 200MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.02MM ANTICODON BINDING DOMAIN REMARK 210 U-15N, 13C; 20MM D-TRIS-HCL REMARK 210 (PH7.5); 200MM NACL; 1MM D-DTT; REMARK 210 0.02% NAN3; 10% D2O; 90% H2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_13C-SEPARATED_NOESY; 3D_15N REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20020425, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.860, CYANA 1.0.7 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS, TARGET REMARK 210 FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLN A 94 H MET A 98 1.54 REMARK 500 H ILE A 14 O ILE A 65 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 2 -58.55 -161.48 REMARK 500 1 SER A 3 -58.62 -147.68 REMARK 500 1 SER A 6 -56.65 -175.50 REMARK 500 1 THR A 20 49.25 -85.35 REMARK 500 1 SER A 26 -67.28 -91.37 REMARK 500 1 VAL A 27 -34.19 -39.38 REMARK 500 1 LEU A 43 59.57 -118.56 REMARK 500 1 ASN A 44 92.25 -64.29 REMARK 500 1 VAL A 47 -156.83 48.66 REMARK 500 1 SER A 61 108.99 -41.33 REMARK 500 1 THR A 85 146.51 -38.77 REMARK 500 1 ASN A 91 94.46 58.87 REMARK 500 1 CYS A 112 -70.39 -68.19 REMARK 500 1 GLU A 114 -62.22 71.24 REMARK 500 1 GLU A 116 97.37 -62.26 REMARK 500 1 ARG A 117 110.36 58.44 REMARK 500 1 GLU A 118 169.62 -45.09 REMARK 500 1 ARG A 122 128.84 -172.58 REMARK 500 1 SER A 125 113.41 58.87 REMARK 500 1 SER A 128 98.14 51.25 REMARK 500 1 SER A 129 -57.52 -135.86 REMARK 500 2 SER A 5 91.94 -168.58 REMARK 500 2 SER A 6 -56.86 -129.55 REMARK 500 2 GLU A 46 -66.49 -129.56 REMARK 500 2 ASN A 91 92.33 54.88 REMARK 500 2 LYS A 115 63.93 -117.59 REMARK 500 2 GLU A 116 -53.06 -175.83 REMARK 500 2 ARG A 117 108.75 59.46 REMARK 500 2 GLU A 118 -179.80 -49.93 REMARK 500 2 ALA A 121 52.97 -141.71 REMARK 500 2 ARG A 122 107.61 -171.97 REMARK 500 2 ALA A 124 135.59 -179.11 REMARK 500 2 SER A 125 136.86 -175.07 REMARK 500 2 SER A 129 155.26 66.83 REMARK 500 3 SER A 3 155.03 63.76 REMARK 500 3 SER A 5 87.18 51.34 REMARK 500 3 SER A 26 -71.06 -90.94 REMARK 500 3 ASN A 44 118.93 -172.48 REMARK 500 3 GLU A 46 -66.89 -154.61 REMARK 500 3 SER A 61 115.90 -39.15 REMARK 500 3 THR A 68 -152.18 -129.99 REMARK 500 3 ASN A 91 95.72 62.42 REMARK 500 3 GLN A 94 -70.78 -37.90 REMARK 500 3 GLU A 114 92.23 -52.21 REMARK 500 3 LYS A 115 -66.78 -161.92 REMARK 500 3 ARG A 117 105.64 -35.05 REMARK 500 3 GLU A 118 171.39 -45.91 REMARK 500 3 SER A 128 130.64 63.57 REMARK 500 4 SER A 3 170.56 57.17 REMARK 500 4 SER A 6 -48.41 175.60 REMARK 500 REMARK 500 THIS ENTRY HAS 344 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSK002201609.1 RELATED DB: TARGETDB DBREF 1V95 A 8 124 UNP Q9HCD5 NCO5_HUMAN 197 313 SEQADV 1V95 GLY A 1 UNP Q9HCD5 CLONING ARTIFACT SEQADV 1V95 SER A 2 UNP Q9HCD5 CLONING ARTIFACT SEQADV 1V95 SER A 3 UNP Q9HCD5 CLONING ARTIFACT SEQADV 1V95 GLY A 4 UNP Q9HCD5 CLONING ARTIFACT SEQADV 1V95 SER A 5 UNP Q9HCD5 CLONING ARTIFACT SEQADV 1V95 SER A 6 UNP Q9HCD5 CLONING ARTIFACT SEQADV 1V95 GLY A 7 UNP Q9HCD5 CLONING ARTIFACT SEQADV 1V95 SER A 125 UNP Q9HCD5 CLONING ARTIFACT SEQADV 1V95 GLY A 126 UNP Q9HCD5 CLONING ARTIFACT SEQADV 1V95 PRO A 127 UNP Q9HCD5 CLONING ARTIFACT SEQADV 1V95 SER A 128 UNP Q9HCD5 CLONING ARTIFACT SEQADV 1V95 SER A 129 UNP Q9HCD5 CLONING ARTIFACT SEQADV 1V95 GLY A 130 UNP Q9HCD5 CLONING ARTIFACT SEQRES 1 A 130 GLY SER SER GLY SER SER GLY PRO VAL ASP CYS SER VAL SEQRES 2 A 130 ILE VAL VAL ASN LYS GLN THR LYS ASP TYR ALA GLU SER SEQRES 3 A 130 VAL GLY ARG LYS VAL ARG ASP LEU GLY MET VAL VAL ASP SEQRES 4 A 130 LEU ILE PHE LEU ASN THR GLU VAL SER LEU SER GLN ALA SEQRES 5 A 130 LEU GLU ASP VAL SER ARG GLY GLY SER PRO PHE ALA ILE SEQRES 6 A 130 VAL ILE THR GLN GLN HIS GLN ILE HIS ARG SER CYS THR SEQRES 7 A 130 VAL ASN ILE MET PHE GLY THR PRO GLN GLU HIS ARG ASN SEQRES 8 A 130 MET PRO GLN ALA ASP ALA MET VAL LEU VAL ALA ARG ASN SEQRES 9 A 130 TYR GLU ARG TYR LYS ASN GLU CYS ARG GLU LYS GLU ARG SEQRES 10 A 130 GLU GLU ILE ALA ARG GLN ALA SER GLY PRO SER SER GLY HELIX 1 1 GLN A 19 THR A 20 5 2 HELIX 2 2 LYS A 21 ASP A 33 1 13 HELIX 3 3 LEU A 49 GLY A 60 1 12 HELIX 4 4 THR A 68 HIS A 74 1 7 HELIX 5 5 GLN A 94 GLU A 114 1 21 SHEET 1 A 5 VAL A 38 LEU A 43 0 SHEET 2 A 5 CYS A 11 VAL A 16 1 N VAL A 13 O ASP A 39 SHEET 3 A 5 PHE A 63 ILE A 67 1 O ILE A 65 N ILE A 14 SHEET 4 A 5 SER A 76 ILE A 81 -1 O ASN A 80 N ALA A 64 SHEET 5 A 5 GLU A 88 PRO A 93 -1 O HIS A 89 N VAL A 79 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1